Search
Telomir Pharmaceuticals Inc
TELOAdd to Watchlist
1.099USD
+0.009+0.87%
Market hours （ET）Quotes delayed by 15 min
75.62MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14No earnings forecast score is currently available for Telomir Pharmaceuticals Inc. The Pharmaceuticals industry's average is 7.87. The average price target is 15.50, with a high of 15.50 and a low of 15.50.
Analyst Rating
Based on
0
analysts
--
Current Rating
15.500
Target Price
+1120.47%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Biogen Inc
BIIB
37
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Regeneron Pharmaceuticals Inc
REGN
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Telomir Pharmaceuticals Inc's price target?
Analysts forecast that Telomir Pharmaceuticals Inc's price target is USD 15.50, with the highest forecast at USD 15.50 and the lowest forecast at USD 15.50.
How have Telomir Pharmaceuticals IncTELO's recent earnings per share performed?
The market expectation was USD -0.79, while Telomir Pharmaceuticals IncTELO's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD -0.08.